Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer

Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer

Abstract Background Circulating tumor DNA (ctDNA) is a promising biomarker for predicting relapse in multiple solid cancers. However, the predictive value of ctDNA for disease recurrence remains indefinite in locoregional gastric cancer (GC). Here, we aimed to evaluate the predictive value of ctDNA...

Full description

Bibliographic Details
Main Authors: Shu‐Qiang Yuan, Run‐Cong Nie, You‐Sheng Huang, Ying‐Bo Chen, Si‐Yu Wang, Xiao‐Wei Sun, Yuan‐Fang Li, Ze‐Kun Liu, Yan‐Xing Chen, Yi‐Chen Yao, Yu Xu, Hai‐Bo Qiu, Yao Liang, Wei Wang, Ze‐Xian Liu, Qi Zhao, Rui‐Hua Xu, Zhi‐Wei Zhou, Feng Wang
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Cancer Communications
Subjects:
gastric cancer
ctDNA
chemotherapy
postoperative
recurrence
Online Access:https://doi.org/10.1002/cac2.12494

Internet

https://doi.org/10.1002/cac2.12494

Similar Items